Literature DB >> 7132570

Changes in hepatic energy charge, blood ketone body ratio, and indocyanine green clearance in relation to DNA synthesis after hepatectomy.

K Ozawa, T Fujimoto, T Nakatani, M Asano, H Aoyama, T Tobe.   

Abstract

The changes in the energy charge (ATP + 0.5 ADP)/(ATP + ADP + AMP) levels of the remnant liver were studied in relation to changes in the incorporation rate of methyl-3H-thymidine into DNA, the blood ratio of acetoacetate/beta-hydroxybutyrate and indocyanine green (ICG) clearance in 70% hepatectomized rabbits. The energy charge levels of the remnant liver decreased rapidly to 0.767 from 0.856 of normal, despite a marked enhancement of mitochondrial phosphorylative activity, concomitant with the fall in blood ketone body ratio, before a maximal increase of DNA synthesis after hepatectomy. Blood ketone body ratio was correlated with hepatic energy charge (r = 0.696, p less than 0.01). After a maximal increase of DNA synthesis, hepatic energy charge levels and the blood ketone body ratios increased gradually to normal levels, concomitant with a rise in ICG clearance. Energy charge levels of the remnant liver can be evaluated by the blood ketone body ratio.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7132570     DOI: 10.1016/0024-3205(82)90765-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Initial hepatic metabolic function in canine liver and pancreas cluster transplantation.

Authors:  M Hisanaga; Y Nakajima; M Segawa; M Matsumoto; T Fukuoka; H Yabuuchi; K Kido; M Horikawa; J Taki; A Yoshimura
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

Review 2.  Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation.

Authors:  D Gomez; S Homer-Vanniasinkam; A M Graham; K R Prasad
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

3.  Response of hepatic mitochondrial redox state to oral glucose load. Redox tolerance test as a new predictor of surgical risk in hepatectomy.

Authors:  K Mori; K Ozawa; Y Yamamoto; A Maki; Y Shimahara; N Kobayashi; Y Yamaoka; K Kumada
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

4.  Determination of the extent of feasible hepatic resection from hepatic blood flow.

Authors:  H Mimura; N Takakura; Y Ohno; T Matsuda; H Kin; K Hamazaki; M Tsumura; S Toda; Y Hiraki
Journal:  World J Surg       Date:  1986-04       Impact factor: 3.352

5.  Successful management of portal hypertension following artificial arterioportal shunting: report of a case.

Authors:  S Ko; Y Nakajima; H Kanehiro; Y Aomatsu; A Yoshimura; J Taki; M Ueno; T Kin; H Nakano
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

6.  Effect of prostaglandin E1 on arterial ketone body ratio in hepatectomy.

Authors:  J Hayakawa; G Yoshida; Y Usuda
Journal:  J Anesth       Date:  1994-06       Impact factor: 2.078

7.  Hemodynamic and oxygen delivery-consumption changes during partial liver resection.

Authors:  H Iwasaka; T Kitano; A Mizutani; K Taniguchi; N Honda; Y I Kim; M Kobayashi
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

8.  A correlation between arterial ketone body ratio and concentration of beta-hydroxybutyrate as an indicator of hepatic functional reserve.

Authors:  M Hamanoue; T Aikou; G Tanabe; S Takao; H Shimazu; K Kimotsuki; M Nagashige
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

9.  Hepatic mitochondrial redox state in hypotensive brain-dead patients and an effect of dopamine administration.

Authors:  T Nakatani; Y Ishikawa; K Kobayashi; K Ozawa
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

10.  Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin.

Authors:  Hiroshi Kono; Hideki Fujii; Masami Asakawa; Masayuki Yamamoto; Masanori Matsuda; Akira Maki; Yoshiro Matsumoto
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.